Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Exploring Sexually Transmitted and Bloodborne Infection Rates in Florida After Implementation of Syringe Services Programs: A Quasi-Experimental Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users
10.1007/s10461-012-0276-0 · 2013 · External reference
Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992–2013
10.1016/j.annepidem.2020.03.011 · 2020 · External reference
Prevalence and modes of transmission of hepatitis C virus infection: a historical worldwide review
10.3390/v16071115 · 2024 · External reference
Sexual risk behaviors and STDs among persons who inject drugs: a national study
10.1016/j.ypmed.2019.105779 · 2019 · External reference
Narrative review: sexually transmitted diseases and homeless youth-what do we know about sexually transmitted disease prevalence and risk?
10.1097/olq.0000000000000633 · 2017 · External reference
Increased methamphetamine, injection drug, and heroin use among women and heterosexual men with primary and secondary syphilis - United States, 2013–2017
10.15585/mmwr.mm6806a4 · 2019 · External reference
Strategies used by people who inject drugs to avoid stigma in healthcare settings
10.1016/j.drugalcdep.2019.01.037 · 2019 · External reference
Effectiveness of needle and syringe Programmes in people who inject drugs - an overview of systematic reviews
10.1186/s12889-017-4210-2 · 2017 · External reference
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020
10.1016/j.drugalcdep.2022.109323 · 2022 · External reference
Reaching people who use drugs with sexual and reproductive healthcare through syringe services programs: potential promise and missed opportunities
10.1186/s12954-024-01116-5 · 2024 · External reference
Expansion of syringe service programs in the United States, 2015–2018
10.2105/ajph.2019.305515 · 2020 · External reference
Unresolved reference
External reference
A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs
10.1016/j.drugalcdep.2011.12.001 · 2012 · External reference
The University of Miami infectious disease elimination act syringe services program: a blueprint for student advocacy, education, and innovation
10.1097/acm.0000000000003557 · 2021 · External reference
Student-run free clinic at a syringe services program, Miami, Florida, 2017–2019
10.2105/ajph.2020.305705 · 2020 · External reference
Implementation and first-year operating costs of an academic medical center-based syringe services program
10.1186/s12954-021-00563-8 · 2021 · External reference
Financial barriers, facilitators, and strategies among syringe services programs in the U.S., and their impact on implementation and health outcomes
10.1016/j.ssmqr.2024.100421 · 2024 · External reference
Using interrupted time series analysis to measure the impact of legalized syringe exchange on HIV diagnoses in Baltimore and Philadelphia
10.1097/qai.0000000000002176 · 2019 · External reference
Implementation of syringe services programs to prevent rapid human immunodeficiency virus transmission in rural counties in the United States: a modeling study
10.1093/cid/ciz321 · 2020 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Difference-in-difference in the time of cholera: a gentle introduction for epidemiologists
10.1007/s40471-020-00245-2 · 2020 · External reference
Designing difference in difference studies: best practices for public health policy research
10.1146/annurev-publhealth-040617-013507 · 2018 · External reference
Difference-in-difference estimation using Stata
2022 · External reference
The wild bootstrap with a “small” number of “large” clusters
10.1162/rest_a_00887 · 2021 · External reference
Revising the suspected-cancer guidelines: impacts on patients’ primary care contacts and costs
10.1016/j.jval.2022.06.017 · 2023 · External reference
Unresolved reference
2024 · External reference
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis
10.1093/ije/dyt243 · 2014 · External reference
Making the case for syringe services programs
10.1177/0033354920936233 · 2020 · External reference
The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis
10.1097/qai.0b013e3181a2539a · 2009 · External reference
The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: a modeling study
10.1097/qad.0000000000003199 · 2022 · External reference
Providing reproductive health services for women who inject drugs: a pilot program
10.1186/s12954-020-00395-y · 2020 · External reference
Reducing missed opportunities: pairing sexually transmitted infection screening with syringe exchange services
10.1097/olq.0000000000000516 · 2016 · External reference
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis
10.1111/add.14012 · 2018 · External reference
Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis
10.1186/s12954-017-0156-z · 2017 · External reference
Per-contact infectivity of hepatitis C virus acquisition in association with receptive needle sharing exposures in a prospective cohort of young adult people who inject drugs in San Francisco, California
10.1093/ofid/ofaa092 · 2020 · External reference
Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis
10.1186/s12954-021-00505-4 · 2021 · External reference
Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida
10.1016/j.jsat.2021.108344 · 2021 · External reference
Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions
10.1371/journal.pone.0104515 · 2014 · External reference
Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019–2020
10.1016/j.drugpo.2023.104289 · 2024 · External reference
Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
10.1186/s12954-020-00385-0 · 2020 · External reference
The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: an Australian pilot study
10.1111/jvh.13664 · 2022 · External reference
Approaches to offering hepatitis C treatment at syringe services programs in the United States: a scoping review
10.1093/ofid/ofaf211 · 2025 · External reference
‘New evidence’ for Syringe Services Programs? A call for rigor and skepticism
10.1016/j.drugpo.2023.104107 · 2023 · External reference
Unresolved reference
External reference
